Apoptosis induced by proteasome inhibition in human myoblast cultures

European Journal of Histochemistry

Volumn 50, Issue 2, 2006, Pages 109-118

  Sassone, J ^a   Ciammola, Andrea ^a,c   Tiloca, C ^a   Glionna, M ^a   Meola, G ^a   Mancinelli, E ^b   Silani, V ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c ISTITUTO AUXOLOGICO ITALIANO   (Italy)

Author keywords

Aggregates; Apoptosis; Myoblasts; Proteasome

Indexed keywords

CASPASE 3; PROTEASOME; ANTINEOPLASTIC AGENT; BENZYLOXYCARBONYLLEUCYL LEUCYL LEUCINE ALDEHYDE; BENZYLOXYCARBONYLLEUCYL-LEUCYL-LEUCINE ALDEHYDE; LEUPEPTIN; UBIQUITIN;

APOPTOSIS; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; MYOBLAST; UBIQUITINATION; ADULT; BIOLOGICAL MODEL; CELL INCLUSION; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM;

ADULT; ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; CELL SURVIVAL; CELLS, CULTURED; HUMANS; INCLUSION BODIES; LEUPEPTINS; MODELS, BIOLOGICAL; MYOBLASTS; PROTEASOME ENDOPEPTIDASE COMPLEX; UBIQUITIN;

EID: 39049186569     PISSN: 1121760X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Abu-Baker A, Messaed C, Laganiere J, Gaspar C, Brais B, Rouleau GA. Involvement of the ubiquitin-proteasome pathway and molecular chaperones in oculopharyngeal muscular dystrophy. Hum Mol Genet 2003; 12:2609-23.
2. Alves-Rodrigues A, Gregori L, Figueiredo-Pereira ME. Ubiquitin, cellular inclusions and their role in neurodegeneration. Trends Neurosci 1998; 21:516-20.
3. Askanas V, Serdaroglu P, Engel WK, Alvarez RB. Immunolocalization of ubiquitin in muscle biopsies of patients with inclusion body myositis and oculopharyngeal muscular dystrophy. Neurosci Lett 1991; 130:73-6.
4. Bellas RE, FitzGerald MJ, Fausto N, Sonenshein GE. Inhibition of NF-kappa B activity induces apoptosis in murine hepatocytes. Am J Pathol 1997; 151:891-6.
5. Blau HM, Webster C. Isolation and characterization of human muscle cells. Proc Natl Acad Sci U S A 1981; 78:5623-7.
6. Bockhold KJ, Rosenblatt JD, Partridge TA. Aging normal and dystrophic mouse muscle: analysis of myogenicity in cultures of living single fibers. Muscle Nerve 1998; 21:173-83.
7. Bucciantini M, Giannoni E, Chiti F, Baroni F, Formigli L, Zurdo J et al. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 2002; 416:507-11.
8. Calado A, Tome FM, Brais B, Rouleau GA, Kuhn U, Wahle E et al. Nuclear inclusions in oculopharyngeal muscular dystrophy consist of poly(A) binding protein 2 aggregates which sequester poly(A) RNA. Hum Mol Genet 2000; 9:2321-8.
9. Canu N, Barbato C, Ciotti MT, Serafino A, Dus L, Calissano P. Proteasome involvement and accumulation of ubiquitinated proteins in cerebellar granule neurons undergoing apoptosis. J Neurosci 2000; 20:589-99.
10. Charge SB, Rudnicki MA. Cellular and molecular regulation of muscle regeneration. Physiol Rev 2004; 84:209-38.
11. Chen L, Smith L, Wang Z, Smith JB. Preservation of caspase-3 subunits from degradation contributes to apoptosis evoked by lactacystin: any single lysine or lysine pair of the small subunit is sufficient for ubiquitination. Mol Pharmacol 2003; 64:334-45.
12. Columbaro M, Mattioli E, Lattanzi G, Rutigliano C, Ognibene A, Maraldi NM, Squarzoni S. Staurosporine treatment and serum starvation promote the cleavage of emerin in cultured mouse myoblasts: involvement of a caspase-dependent mechanism. FEBS Lett. 2001; 509:423-9.
13. De Bleecker JL, Engel AG, Ertl BB. Myofibrillar myopathy with abnormal foci of desmin positivity. II. Immunocytochemical analysis reveals accumulation of multiple other proteins. J Neuropathol Exp Neurol 1996; 55:563-77.
14. Drexler HC. Activation of the cell death program by inhibition of proteasome function. Proc Natl Acad Sci USA 1997; 94:855-60.
15. Ferrer I, Martin B, Castano JG, Lucas JJ, Moreno D, Olive M. Proteasomal expression, induction of immunoproteasome subunits, and local MHC class I presentation in myofibrillar myopathy and inclusion body myositis. J Neuropathol Exp Neurol 2004; 63:484-98.
16. Ferrington DA, Husom AD, Thompson LV. Altered proteasome structure, function, and oxidation in aged muscle. FASEB J 2005; 19:644-6.
17. Figueiredo-Pereira ME, Banik N, Wilk S. Comparison of the Effect of Calpain Inhibitors on Two Extralysosomal Proteinases: The Multicatalytic Proteinase Complex and m-Calpain. Journal of Neurochemistry 1994; 62:1989-94.
18. Fratta P, Engel WK, McFerrin J, Davies KJ, Lin SW, Askanas V. Proteasome inhibition and aggresome formation in sporadic inclusion-body myositis and in amyloid-beta precursor protein-overexpressing cultured human muscle fibers. Am J Pathol 2005; 167:517-26.
19. Fratta P, Engel WK, Van Leeuwen FW, Hol EM, Vattemi G, Askanas V. Mutant ubiquitin UBB+1 is accumulated in sporadic inclusion-body myositis muscle fibers. Neurology 2004; 63:1114-7.
20. Furling D, Coiffier L, Mouly V, Barbet JP, St Guily JL, Taneja K et al. Defective satellite cells in congenital myotonic dystrophy. Hum Mol Genet 2001; 10:2079-87.
21. Glickman MH, Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 2002; 82:373-428.
22. Heslop L, Morgan JE, Partridge TA. Evidence for a myogenic stem cell that is exhausted in dystrophic muscle. J Cell Sci 2000; 113:2299-308.
23. Husom AD, Peters EA, Kolling EA, Fugere NA, Thompson LV, Ferrington DA. Altered proteasome function and subunit composition in aged muscle. Arch Biochem Biophys 2004; 421:67-76.
24. Kaufman SJ, Foster RF. Replicating myoblasts express a muscle-specific phenotype. Proc Natl Acad Sci U S A 1988; 85:9606-9610.
25. Lopes UG, Erhardt P, Yao R, Cooper GM. p53-dependent induction of apoptosis by proteasome inhibitors. J Biol Chem 1997; 272:12893-6.
26. Lu M, Kitson RP, Xue Y, Goldfarb RH. Activation of multiple caspases and modification of cell surface fas (CD95) in proteasome inhibitor-induced apoptosis of rat natural killer cells. J Cell Biochem 2003; 88:482-92.
27. Martinez-Vicente M, Sovak G, Cuervo AM. Protein degradation and aging. Exp Gerontol 2005; 40:622-33.
28. Meola G, Velicogna M, Brigato C, Pizzul S, Rotondo G, Scarlato G. Growth and differentiation of myogenic clones from adult human muscle cell cultures. Eur J Basic Appl Histochem 1991; 35:219-131.
29. Mitsiades N, Mitsiades CS, Poulaki V, Chauhan D, Fanourakis G, Gu X et al. Molecular sequelae of proteasome inhibition in human multiple myeloma cells. Proc Natl Acad Sci U S A 2002; 99:14374-9.
30. Shinohara K, Tomioka M, Nakano H, Tone S, Ito H, Kawashima S. Apoptosis induction resulting from proteasome inhibition. Biochem J 1996; 317:385-8.
31. Tews DS. Muscle-fiber apoptosis in neuromuscular diseases. Muscle Nerve 2005; 32:443-58.
32. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998; 281:1312-6.
33. Wagenknecht B, Hermisson M, Groscurth P, Liston P, Krammer PH, Weller M. Proteasome inhibitor-induced apoptosis of glioma cells involves the processing of multiple caspases and cytochrome c release. Neurochem 2000; 75:2288-97.
34. Webster C, Blau HM. Accelerated age-related decline in replicative life-span of Duchenne muscular dystrophy myoblasts: implications for cell and gene therapy. Somat Cell Mol Genet 1990; 16:557-65.
35. Suzuki Y, Nakabayashi Y, Takahashi R. Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death. Proc Natl Acad Sci U S A 2001; 98:8662-7.
36. Zhang XM, Lin H, Chen C, Chen BD. Inhibition of ubiquitin-proteasome pathway activates a caspase-3-like protease and induces Bcl-2 cleavage in human M-07e leukaemic cells. Biochem J 1999; 340:127-33.